Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Are ubiquitination pathways central to Parkinson s disease?Giasson BI; Lee VMCell 2003[Jul]; 114 (1): 1-8Parkinson's disease (PD) is the most common neurodegenerative movement disorder. The major motor disabilities of PD are associated with the extensive loss of dopaminergic neurons in the substantia nigra pars compacta. The physiological changes and biochemical pathways involved in the selective demise of these neurons are still unclear. Recent studies have demonstrated that alterations or reductions in ubiquitin-mediated proteasome function can be causal of at least some forms of parkinsonism, and multiple lines of evidence suggest that this mechanism of protein degradation may play an important role in the etiology of PD.|*Ubiquitin-Protein Ligases[MESH]|Animals[MESH]|Cysteine Endopeptidases/genetics/*metabolism[MESH]|Drosophila Proteins/metabolism[MESH]|Humans[MESH]|Ligases/deficiency/genetics[MESH]|Multienzyme Complexes/genetics/*metabolism[MESH]|Nerve Tissue Proteins/metabolism[MESH]|Neurons/*metabolism/pathology[MESH]|Parkinson Disease/genetics/*metabolism[MESH]|Proteasome Endopeptidase Complex[MESH]|Receptors, Endothelin[MESH]|Substantia Nigra/*metabolism/pathology/physiopathology[MESH]|Synucleins[MESH]|Thiolester Hydrolases/metabolism[MESH]|Ubiquitin Thiolesterase[MESH]|Ubiquitin/genetics/*metabolism[MESH] |